open access
Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy
open access
Abstract
Background: The aim of this study was to determine the efficacy and safety of levosimendan
in takotsubo cardiomyopathy (TC).
Methods: The study was conducted in a retrospective design and 42 consecutive patients were enrolled in 6 cardiovascular centers in Turkey. The records of TC patients having left ventricular ejection fraction (LVEF) £ 35% were examined at admission, discharge and recovery period including their clinical and echocardiographic data.
Results: Of these 42 TC patients, 17 were treated with loading dose and i.v. infusion of levosimendan (group 1) and 25 were treated without levosimendan (group 2). Echocardiographic findings at admission and at discharge were similar and no serious complications were observed in either group. However recovery period including the interval of 50% increase in LVEF, time to achieve the baseline troponin values and hospitalization were significantly lower
in patients taking levosimendan.
Conclusions: This is the first study using loading dose and subsequent continuous intravenous administration of levosimendan demonstrating accelerated recovery in patients with TC.
Abstract
Background: The aim of this study was to determine the efficacy and safety of levosimendan
in takotsubo cardiomyopathy (TC).
Methods: The study was conducted in a retrospective design and 42 consecutive patients were enrolled in 6 cardiovascular centers in Turkey. The records of TC patients having left ventricular ejection fraction (LVEF) £ 35% were examined at admission, discharge and recovery period including their clinical and echocardiographic data.
Results: Of these 42 TC patients, 17 were treated with loading dose and i.v. infusion of levosimendan (group 1) and 25 were treated without levosimendan (group 2). Echocardiographic findings at admission and at discharge were similar and no serious complications were observed in either group. However recovery period including the interval of 50% increase in LVEF, time to achieve the baseline troponin values and hospitalization were significantly lower
in patients taking levosimendan.
Conclusions: This is the first study using loading dose and subsequent continuous intravenous administration of levosimendan demonstrating accelerated recovery in patients with TC.
Keywords
takotsubo cardiomyopathy; levosimendan; recovery; heart failure; stress cardiomyopathy
About this articleTitle
Levosimendan accelerates recovery in patients with takotsubo cardiomyopathy
Journal
Issue
Pages
610-615
Published online
2016-11-30
DOI
10.5603/CJ.a2016.0100
Pubmed
Bibliographic record
Cardiol J 2016;23(6):610-615.
Keywords
takotsubo cardiomyopathy
levosimendan
recovery
heart failure
stress cardiomyopathy
Authors
Mehmet Yaman
Ugur Arslan
Ahmet Kaya
Aytac Akyol
Fatih Ozturk
Yunus Emre Okudan
Adil Bayramoglu
Osman Bektas